Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

NCT00561795 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Peritoneal Carcinoma
Tumor
Epithelial Ovarian Cancer
Uterine Disease
Cervix Diseases
Neoplasms, Ovarian
Cancer

Interventions

DRUG: pazopanib (GW786034)
DRUG: carboplatin
DRUG: paclitaxel

Sponsor

GlaxoSmithKline